Clinical Focus
Advertisement
Advertisement
Trending on Modern Retina
1
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
2
Timely interventions can protect vision in patients with GA
3
Monitoring MacTel: Why BCVA does not tell the whole story
4
Enhancing Durability and Fluid Control with Aflibercept 8 mg in Retinal Vascular Diseases
5
